Mechanism of Action and Clinical Applications of Anticholinergics

Primary Mechanism and Receptor Specificity

• Anticholinergics prevent the accumulation of acetylcholine at muscarinic receptors, thereby inhibiting parasympathetic nervous system stimulation, as noted by the American Society of Anesthesiologists 1
• The blockade of muscarinic receptors reduces bladder contractions, helping with urinary incontinence, according to the Mayo Clinic Proceedings 2

Tissue-Specific Effects and Clinical Applications

• Anticholinergics reduce excessive lacrimation, salivation, and perspiration by blocking muscarinic stimulation, as reported by the American Society of Anesthesiologists 1
• First-generation anticholinergics can cross the blood-brain barrier and block central muscarinic receptors, leading to cognitive effects, as stated by the Mayo Clinic Proceedings 3
• Newer anticholinergics like tiotropium have limited systemic absorption and minimal central nervous system penetration, as noted by the American College of Chest Physicians 4
• Atropine is the "gold standard" treatment for nerve agent intoxication as it blocks the muscarinic receptor overstimulation caused by acetylcholine accumulation, according to the American Society of Anesthesiologists 1

Adverse Effects Related to Mechanism

• The broad muscarinic receptor blockade results in predictable side effects, including dry mouth, blurred vision, tachycardia, confusion, and hyperthermia, as reported by the American Academy of Pediatrics 5
• Anticholinergic medications are particularly problematic in elderly patients due to age-related decline in cholinergic function, as stated by the Mayo Clinic Proceedings 3

Anticholinergic Effects on the Body

Organ System Effects

• The American Academy of Pediatrics notes that anticholinergics can cause tachycardia due to blockade of vagal tone on the sinoatrial node, as well as mydriasis and cycloplegia from blockade of pupillary constrictor and ciliary muscles 6
• The Mayo Clinic reports that age-related decline in baseline cholinergic function makes elderly patients particularly vulnerable to anticholinergics, which further reduce already diminished acetylcholine activity 7
• The anticholinergic toxidrome demonstrates a full pathophysiologic spectrum when receptor blockade is extensive, including hyperthermia, dry mucous membranes, flushed skin, mydriasis, delirium, urinary retention, hypoactive or absent bowel sounds, and tachycardia 6

Clinical Implications of Pathophysiology

• The Journal of Allergy and Clinical Immunology states that bronchodilation occurs through blockade of vagally mediated bronchial smooth muscle tone, though efficacy varies among patients 8
• The Journal of Allergy and Clinical Immunology also notes that anticholinergics can be used for therapeutic applications, including bronchodilation 9

Mechanism of Anticholinergic Spray for Patulous Eustachian Tube

Primary Therapeutic Mechanism

• The American Academy of Allergy, Asthma, and Immunology recommends anticholinergic agents, which work through blockade of muscarinic receptors in the Eustachian tube mucosa, reducing glandular secretions and promoting mucosal edema, thereby narrowing the abnormally patent tube lumen and restoring valve competence in patients with patulous Eustachian tube 10, 11
• The American Thoracic Society suggests that anticholinergic agents reduce glandular secretions by blocking parasympathetic stimulation of submucosal glands, allowing the tube to maintain a more closed resting state in patients with patulous Eustachian tube 10, 11

Clinical Evidence for Efficacy

• No cited facts are available for this section

Mechanism Differs from Rhinitis Treatment

• The American Academy of Allergy, Asthma, and Immunology notes that intranasal anticholinergics like ipratropium bromide effectively reduce rhinorrhea but have minimal effects on nasal congestion, and when applied to the Eustachian tube region, the anticholinergic effect on local tissue dynamics becomes therapeutically relevant 10

Anticholinergic Pathophysiology and Clinical Effects

Central Nervous System Effects

• The American Society of Anesthesiologists notes that central anticholinergic effects, including agitation, seizures, restlessness, hallucinations, disorientation, anxiety, confusion, and delirium, can occur due to acetylcholine blockade in the CNS, which is involved in nociception through the endorphinergic and serotoninergic systems, explaining some analgesic interactions, as seen in nerve agent intoxication 12

Peripheral Nervous System Effects

• The Anesthesiology society recommends that anticholinergics reduce bronchorrhea and bronchospasm by preventing muscarinic receptor activation in the airways, causing bronchodilation, though efficacy varies among patients 12
• The Anesthesiology society notes that excess acetylcholine, as in nerve agent poisoning, causes initial nicotinic sympathetic hyperstimulation followed by muscarinic activation with bradycardia, heart block, QT prolongation, arrhythmias, and hypotension, in contrast to the tachycardia caused by anticholinergic blockade of vagal tone on the sinoatrial node 13
• The Anesthesiology society states that anticholinergics can cause gastrointestinal effects, including reduced smooth muscle motility, leading to hypoactive or absent bowel sounds, constipation, and in severe cases, ileus or urinary retention, in contrast to the hypermotility caused by excess acetylcholine 12

Tissue-Specific Pathophysiology

• The Anesthesiology society explains that classic anticholinergics primarily block muscarinic receptors and have minimal effect on nicotinic receptors at the neuromuscular junction, whereas nerve agent poisoning causes nicotinic receptor overstimulation, leading to involuntary fasciculation, weakness, and flaccid paralysis 12
• The Anesthesiology society notes that visceral smooth muscle, cardiac muscle, and secretory glands are influenced through muscarinic hyperstimulation, while autonomic ganglia and skeletal muscle are affected through nicotinic mechanisms in cases of nerve agent poisoning 12

Therapeutic Applications

• The Anesthesiology society recommends atropine as the "gold standard" treatment for nerve agent intoxication, as it blocks muscarinic receptor overstimulation caused by acetylcholine accumulation, but does not address nicotinic effects at the neuromuscular junction, which require oximes 12